E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Articles
- Page Path
- HOME > J Liver Cancer > Volume 12(2); 2012 > Article
- Case Report A Case of Hepatocellular Carcinoma which Showed Response to Transarterial Chemoembolization with DC Bead® in the Patient who Showed No Response to Conventional Transarterial Chemoembolization
- Do Seon Song1, Hee Yeon Kim1, Myeong Jun Song1, Si Hyun Bae1, Jong Young Choi1, Seung Kew Yoon1, Ho Jong Chun2
-
Journal of Liver Cancer 2012;12(2):133-136
DOI: https://doi.org/
Published online: September 30, 2012
1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
2Department of Radiology, College of Medicine, The Catholic University of Korea, Seoul, Korea
2Department of Radiology, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
Corresponding author:
Seung Kew Yoon,
Email: yoonsk@catholic.ac.kr
- 608 Views
- 1 Download
- 0 Crossref
- 0 Scopus
Abstract
Hepatocellular carcinoma (HCC) is one of the most important cause of cancer death in South Korea. Approximately two thirds of the HCC patients are diagnosed in the unresectable stage. Conventional transarterial chemoembolization (TACE) showed survival benefit in the unresectable HCC patients, but it had some limitations, such as low response rate and systemic toxicity. Drug eluting bead has been reported low systemic toxicity and higher tumor necrosis rate. We report a case which showed response to TACE with DC bead in patient that showed no response to conventional TACE.
- Related articles
-
Follow JLC on Twitter